Evidence map›Paper›PMID 26666762›Full record

ArticleChinese journal of integrative medicine2016

Wenxia Changfu Formula () induces apoptosis of lung adenocarcinoma in a transplanted tumor model of drug-resistance nude mice.

Xu-Ming Ji, Zhi-Chun Wu, Guo-Wei Liu, Hua-Yun Yu, Heng Liu, Zheng-Tao Wang, Xiao-Hui Wei, Bing Ouyang

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Aconitine inhibits the proliferation of hepatocellular carcinoma by inducing apoptosis.International journal of clinical and experimental pathology · 2018
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xu-Ming JiSchool of Basic Medical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Zhi-Chun WuSchool of Basic Medical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. doctoroy@sina.com.
Guo-Wei LiuSchool of Basic Medical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Hua-Yun YuSchool of Basic Medical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Heng LiuDepartment of Neurology, Qilu Hospital, Shandong University, Jinan, 250012, China.
Zheng-Tao WangInstitute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Xiao-Hui WeiInstitute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Bing OuyangSchool of Basic Medical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Shandong University of Traditional Chinese Medicine · CNShanghai University of Traditional Chinese Medicine · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the apoptosis mechanism of Wenxia Changfu Formula (, WCF) in reversing drug resistance of lung cancer in vivo.

methodsThirty model mice were randomly assigned to three groups: control group, cisplatin (CDDP) group, and WCF group. A transplanted tumor model of lung adenocarcinoma was established in all groups. Mice in the WCF group received intragastric administration of WCF (0.2 mL/10 g body weight) everyday in addition to CDDP intraperitoneally (5 mg/kg body weight) twice a week. The mice in the CDDP group received CDDP intraperitoneally (5 mg/kg body weight) twice a week, while the control group received normal saline intraperitoneally (0.2 mL/10 g body weight) everyday. The weight of the nude mice and respective tumors, tumor volume and tumor-inhibiting rate were measured. Electron microscopy was used to observe the existence of apoptosis body. Apoptosis index (AI) was detected by TdT-mediated dUTP nick end labeling staining. The expression of Fas and FasL mRNA was investigated by reverse transcription polymerase chain reaction, while immunohistochemistry was applied to detect the protein expression of Fas and FasL, caspase-3 and caspase-activated DNase (CAD), respectively.

resultsCompared with CDDP group and control group, WCF could significantly reduce the tumor volume from the 19th day and alleviate the tumor weight (P <0.05), and the apoptosis body was found in tumor cells in the WCF group. WCF could also enhance the level of AI, up-regulate the expression of caspase apoptosis pathway related protein caspase-3 and CAD, as well as the expression of Fas, FasL mRNA and protein (P <0.05).

conclusionWCF could improve the sensitivity of tumor cells to CDDP and reverse the drug resistance by inducing the apoptosis.

Indexed as

ApoptosisDrug Resistance, NeoplasmXenograft Model Antitumor AssaysAdenocarcinomaAdenocarcinoma of LungAnimalsCaspase 3Cell Line, TumorChromatography, High Pressure LiquidCisplatinDrugs, Chinese HerbalFas Ligand Proteinfas ReceptorFemaleFluorescent Antibody TechniqueHumansCaspase 3CisplatinDrugs, Chinese HerbalFas Ligand ProteinFas protein, mousefas ReceptorRNA, Messengerwenxia changfuanimal modelapoptosisdrug resistancein vivoWenxia Changfu Formula

Identifiers

PMID26666762
OpenAlexW2412426910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.